Prestige Consumer Healthcare (PBH)
(Delayed Data from NYSE)
$59.58 USD
+0.78 (1.33%)
Updated Jul 1, 2022 04:00 PM ET
4-Sell of 5 4
B Value C Growth F Momentum C VGM
Balance Sheet
Fiscal Year End for Prestige Consumer Healthcare Inc falls in the month of March.
All items in Millions except Per Share data.
3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 27 | 32 | 95 | 28 | 33 |
Receivables | 139 | 115 | 151 | 149 | 141 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 120 | 115 | 116 | 120 | 119 |
Other Current Assets | 6 | 8 | 4 | 5 | 12 |
Total Current Assets | 293 | 270 | 366 | 301 | 303 |
Net Property & Equipment | 71 | 70 | 56 | 51 | 53 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 3,276 | 3,054 | 3,055 | 3,086 | 3,401 |
Deposits & Other Assets | 3 | 3 | 3 | 3 | 4 |
Total Assets | 3,671 | 3,429 | 3,514 | 3,441 | 3,761 |
Liabilities & Shareholders Equity | 3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 56 | 46 | 62 | 57 | 61 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 3 | 3 | 1 | 0 | 0 |
Accrued Expenses | 79 | 68 | 81 | 70 | 62 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 143 | 122 | 150 | 127 | 123 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 445 | 434 | 408 | 400 | 443 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 1,477 | 1,480 | 1,730 | 1,799 | 1,993 |
Non-Current Capital Leases | 5 | 7 | 5 | 0 | 0 |
Other Non-Current Liabilities | 7 | 9 | 25 | 20 | 23 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 2,093 | 2,071 | 2,343 | 2,345 | 2,582 |
Shareholders Equity | 3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 1 | 1 | 1 |
Capital Surplus | 516 | 500 | 488 | 479 | 469 |
Retained Earnings | 1,214 | 1,009 | 844 | 702 | 736 |
Other Equity | -19 | -20 | -44 | -26 | -19 |
Treasury Stock | 134 | 131 | 118 | 60 | 8 |
Total Shareholder's Equity | 1,578 | 1,358 | 1,171 | 1,096 | 1,179 |
Total Liabilities & Shareholder's Equity | 3,671 | 3,429 | 3,514 | 3,441 | 3,761 |
Total Common Equity | 1,578 | 1,358 | 1,171 | 1,096 | 1,179 |
Shares Outstanding | 50.20 | 49.80 | 50.20 | 51.80 | 53.00 |
Book Value Per Share | 31.43 | 27.28 | 23.33 | 21.16 | 22.24 |
Fiscal Year End for Prestige Consumer Healthcare Inc falls in the month of March.
All items in Millions except Per Share data.
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 27 | 21 | 43 | 164 | 32 |
Receivables | 139 | 134 | 147 | 130 | 115 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 120 | 106 | 108 | 106 | 115 |
Other Current Assets | 6 | 14 | 8 | 9 | 8 |
Total Current Assets | 293 | 275 | 305 | 409 | 270 |
Net Property & Equipment | 71 | 70 | 70 | 70 | 70 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 3,276 | 3,283 | 3,269 | 3,048 | 3,054 |
Deposits & Other Assets | 3 | 3 | 3 | 3 | 3 |
Total Assets | 3,671 | 3,659 | 3,676 | 3,559 | 3,429 |
Liabilities & Shareholders Equity | 6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 56 | 40 | 38 | 31 | 46 |
Current Portion Long-Term Debt | 0 | 0 | 6 | 0 | 0 |
Current Portion Capital Leases | 3 | 3 | 3 | 3 | 3 |
Accrued Expenses | 79 | 86 | 96 | 86 | 68 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 143 | 135 | 149 | 125 | 122 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 445 | 445 | 440 | 439 | 434 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 1,477 | 1,530 | 1,593 | 1,545 | 1,480 |
Non-Current Capital Leases | 5 | 5 | 5 | 6 | 7 |
Other Non-Current Liabilities | 7 | 8 | 9 | 9 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 2,093 | 2,141 | 2,214 | 2,143 | 2,071 |
Shareholders Equity | 6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 1 | 1 | 1 |
Capital Surplus | 516 | 513 | 507 | 504 | 500 |
Retained Earnings | 1,214 | 1,162 | 1,112 | 1,067 | 1,009 |
Other Equity | -19 | -23 | -24 | -21 | -20 |
Treasury Stock | 134 | 134 | 134 | 134 | 131 |
Total Shareholder's Equity | 1,578 | 1,518 | 1,462 | 1,416 | 1,358 |
Total Liabilities & Shareholder's Equity | 3,671 | 3,659 | 3,676 | 3,559 | 3,429 |
Total Common Equity | 1,578 | 1,518 | 1,462 | 1,416 | 1,358 |
Shares Outstanding | 50.20 | 50.20 | 50.10 | 50.00 | 49.80 |
Book Value Per Share | 31.43 | 30.25 | 29.17 | 28.33 | 27.28 |